Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 11, 2025, before the open
10-Q filed Aug 11, 2025, 42 days after period end · 0001171843-25-005287
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $20.45M | $23.10M | $28.76M | $29.21M |
| Net Income | -$2.28M | -$2.93M | -$980.00K | $2.44M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.52 |
| -$0.07 |
| -$0.02 |
| $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
